1. Home
  2. FTFT vs BRTX Comparison

FTFT vs BRTX Comparison

Compare FTFT & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Future FinTech Group Inc.

FTFT

Future FinTech Group Inc.

HOLD

Current Price

$1.63

Market Cap

10.3M

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$0.22

Market Cap

9.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTFT
BRTX
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Managed Health Care
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3M
9.3M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
FTFT
BRTX
Price
$1.63
$0.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.8K
1.9M
Earning Date
01-01-0001
02-22-2026
Dividend Yield
N/A
N/A
EPS Growth
31.14
66.08
EPS
N/A
N/A
Revenue
$2,158,125.00
$81,000.00
Revenue This Year
N/A
$24.64
Revenue Next Year
N/A
$287.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.21
52 Week High
$4.03
$2.28

Technical Indicators

Market Signals
Indicator
FTFT
BRTX
Relative Strength Index (RSI) 50.89 13.02
Support Level $1.42 $0.22
Resistance Level $1.74 $0.29
Average True Range (ATR) 0.19 0.09
MACD -0.05 -0.07
Stochastic Oscillator 35.08 2.93

Price Performance

Historical Comparison
FTFT
BRTX

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: